Lexaria Awarded New Patents
Accesswire
*Lexaria receives new patents in the fields of epilepsy and anti-viral agents*
*KELOWNA, BC / ACCESSWIRE / April 2, 2024..
Brain Seizures
News and Video Search Results
News coverage
-
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%
GlobeNewswire
-
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
GlobeNewswire
-
Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034: Visiongain
GlobeNewswire
-
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Accesswire
0 shares
1 views
You might like
Brain Seizures media coverage
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
GlobeNewswire
· PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and..
-
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
GlobeNewswire
-
All-In Nutritionals and Autism Today's CEOs Create Joint Company, Neuro Nutritionals, to Support Autism and Neurodiverse Community
Accesswire
-
Revive Therapeutics Provides Corporate Update
GlobeNewswire
-
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
PR Newswire Asia
Advertisement
More coverage
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
GlobeNewswire
Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first..
-
Hillingdon Brain Tumour & Injury Group launches its urgent “Lifeline Appeal” enabling delivery of vital services
Pressat
-
Epilepsy Market to Observe Stunning Growth by 2032, Predicts DelveInsight | Key Players in the Market - Xenon Pharmaceuticals, Aquestive Therapeutics, Takeda, Ovid Therapeutics, Eisai, Biohaven Pharmaceuticals, UCB Pharma
GlobeNewswire
-
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
GlobeNewswire
-
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire